Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic

Palo Alto-based Immune-Onc announced last week that co-founder Charlene Liao has wooed fellow Genentech vets Adrian Jubb and An Song to join her in prepping the startup for first-in-human studies, fueled by $33 million in Series B funding. Northern Light Venture Capital, Vivo Capital and the Stanford-StartX Fund are touted as the star investors in the round.